Strabismus And Amblyopia Digital Therapeutics Market Size, Share & Trends Analysis Report By Product | Forecast to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Strabismus And Amblyopia Digital Therapeutics Market Valuation Change Between Now And 2029?
The digital therapeutics market for strabismus and amblyopia has seen a fast-paced expansion in recent times. The market value is projected to increase from $0.55 billion in 2024 to $0.61 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.1%. Key drivers of this growth during the historical period include augmented research and development in digital vision therapy, governmental backing of healthcare innovations, an increase in health insurance coverage for digital health programs, a heightened concentration on individualized medicine, along with a rising understanding about strabismus and amblyopia.
The market size for digital therapeutics in strabismus and amblyopia is projected to experience a fast growth rate over the coming years, potentially reaching $0.93 billion by 2029 with a compound annual growth rate (CAGR) of 10.9%. The anticipated growth within this forecast period is linked to an increasing occurrence of strabismus and amblyopia, a rising demand for regimens that are non-invasive, enhanced dispatch of telemedicine and remote care, a growing emphasis on detecting and intervening these conditions early, and an expanding elderly population. Key trends for the forecast period consist of innovation in digital therapeutics technology, enhancements in app development focusing on eye health, joint efforts between tech firms and medical service providers, integration of wearable technology in eye care, and upgrades in digital diagnostic procedures for eye conditions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24409&type=smp
What Underlying Factors Are Supporting The Strabismus And Amblyopia Digital Therapeutics Market Growth?
The growth of the digital therapeutics market for strabismus and amblyopia is projected to be fueled by the rise in telehealth. Telehealth uses digital communication technology to provide healthcare services, consultations, and remote monitoring between patients and healthcare professionals. The spread of telehealth has been fueled by better access to healthcare, enabling patients in remote or underserved areas to connect with specialists and receive treatment without the need to travel or see doctors in person. Telehealth backs the digital therapeutics for strabismus and amblyopia by providing continuous remote supervision and guidance, offering patients, particularly children, the opportunity to receive steady, supervised treatment at home. For example, Rock Health, an American digital health company, reported that 80% of US residents have used telemedicine at some point, an increase from 72% in 2021. Therefore, the evolution of telehealth is expected to spur the growth of the digital therapeutics market for strabismus and amblyopia.
Which Sub-Segments Are Driving Growth Within The Strabismus And Amblyopia Digital Therapeutics Market?
The strabismus and amblyopia digital therapeuticsmarket covered in this report is segmented –
1) By Type: Software; Hardware
2) By Indication: Strabismus (Crossed Eyes); Amblyopia (Lazy Eye)
3) By Application: Hospital; Ophthalmic Clinic; Other Applications
Subsegments:
1) By Software: Mobile Applications; Virtual Reality (VR) Applications; Augmented Reality (AR) Applications; Web-Based Platforms; Cloud-Based Software
2) By Hardware: Wearable Devices; Visual Stimulus Devices; Headsets; Eye-Tracking Devices; Light Therapy Devices
What Key Trends Are Driving Growth In The Strabismus And Amblyopia Digital Therapeutics Market?
Leading companies within the digital therapeutics market for strabismus and amblyopia are investing in the creation of groundbreaking solutions, like digital treatment devices, to improve visual clarity and eye coordination with engaging exercises. Digital treatment devices are platforms or tools, created with software, that offer medical treatment via active exercises and behavioural modifications on digital platforms. For instance, in April 2022, NovaSight, a medical device firm based in Israel, revealed that the US Food and Drug Administration (FDA) had granted approval for CureSight, a digital treatment device meant to treat amblyopia, also known as lazy eye. This system that tracks eye movement improves stereo and visual acuity by training the eyes to function in unison. Its FDA approval was backed by the results of a randomised, controlled, multicenter study involving 103 children aged between 4 to 9. The CureSight device and the traditional eye patch – currently the accepted standard treatment – were distributed at random among the participants. The study’s encouraging visual results demonstrated the utility of this device.
Which Companies Hold A Competitive Edge In The 1751 Market?
Major companies operating in the strabismus and amblyopia digital therapeutics market are 3M Company, Freedom Scientific Inc., Ocutrx Vision Technologies LLC, Orthoptics Australia Inc., Good-Lite Company, AmblyoPlay, NovaSight Ltd., Luminopia Inc., NeuraSim Health, Bynocs Inc., RevitalVision LLC, Vivid Vision Inc., Binovi Technologies Corp., Wow Vision Therapy, OculoMotor Technologies Inc., Web Vision Therapy, CureSee Vision Therapy, AnteoTech Ltd, VisionBuilder, HTS Vision Therapy Systems
Access The Complete Report Here:
Which Region Dominates The Strabismus And Amblyopia Digital Therapeutics Market Today?
North America was the largest region in the strabismus and amblyopia digital therapeutics market in 2024. The regions covered in the strabismus and amblyopia digital therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=24409&type=smp
Browse Through More Reports Similar to the Global Strabismus And Amblyopia Digital Therapeutics Market 2025, By The Business Research Company
Eye Health Supplements Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/eye-health-supplements-global-market-report
Eye Melanoma Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/eye-melanoma-global-market-report
Eye Tracking Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/eye-tracking-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
